Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Hypertension
    May 2024
  1. TU W, Agarwal R
    Cardiovascular Benefits of Potassium-Enriched Salt Substitution: Promises and Challenges of Secondary Analyses.
    Hypertension. 2024;81:1041-1043.
    >> Share

    April 2024
  2. DZIEDZIC M, Jozefczuk E, Guzik TJ, Siedlinski M, et al
    Interplay Between Plasma Glycine and Branched-Chain Amino Acids Contributes to the Development of Hypertension and Coronary Heart Disease.
    Hypertension. 2024 Apr 8. doi: 10.1161/HYPERTENSIONAHA.123.22649.
    >> Share

  3. HONIGBERG MC, Economy KE, Pabon MA, Wang X, et al
    Coronary Microvascular Function Following Severe Preeclampsia.
    Hypertension. 2024 Apr 2. doi: 10.1161/HYPERTENSIONAHA.124.22905.
    >> Share

    March 2024
  4. MANCIA G, Brunstrom M, Burnier M, Grassi G, et al
    Rationale of the Inclusion of beta-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.
    Hypertension. 2024 Mar 13. doi: 10.1161/HYPERTENSIONAHA.124.22821.
    >> Share

  5. YU J, Arnott C, Li Q, Di Tanna GL, et al
    Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes.
    Hypertension. 2024 Mar 11. doi: 10.1161/HYPERTENSIONAHA.123.22410.
    >> Share

  6. KACIROTI N, Jamerson KA, Brook RD
    Cardiovascular Protection Beyond Blood Pressure-Lowering Redux: The ACCOMPLISH trial.
    Hypertension. 2024;81:e13-e15.
    >> Share

    February 2024
  7. CHOI E, Shimbo D, Chen L, Foti K, et al
    Trends in All-Cause, Cardiovascular, and Noncardiovascular Mortality Among US Adults With Hypertension.
    Hypertension. 2024 Feb 23. doi: 10.1161/HYPERTENSIONAHA.123.22220.
    >> Share

  8. NORTON GR, An DW, Aparicio LS, Yu YL, et al
    Mortality and Cardiovascular End Points In Relation to the Aortic Pulse Wave Components: An Individual-Participant Meta-Analysis.
    Hypertension. 2024 Feb 23. doi: 10.1161/HYPERTENSIONAHA.123.22036.
    >> Share

  9. MANTA E, Thomopoulos C, Kariori M, Polyzos D, et al
    Revisiting Cardiovascular Benefits of Blood Pressure Reduction in Primary and Secondary Prevention: Focus on Targets and Residual Risk-A Systematic Review and Meta-Analysis.
    Hypertension. 2024 Feb 23. doi: 10.1161/HYPERTENSIONAHA.123.22610.
    >> Share

  10. MATTSSON K, Pihlsgard M, Enhorning S, Timpka S, et al
    Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy.
    Hypertension. 2024 Feb 22. doi: 10.1161/HYPERTENSIONAHA.123.22081.
    >> Share

    January 2024
  11. HENRY A, Mangos G, Roberts LM, Brown MA, et al
    Preeclampsia-Associated Cardiovascular Risk Factors 6 Months and 2 Years After Pregnancy: The P4 Study.
    Hypertension. 2024 Jan 30. doi: 10.1161/HYPERTENSIONAHA.123.21890.
    >> Share

  12. HUANG YZ, Wu JC, Lu GF, Li HB, et al
    Pulmonary Hypertension Induces Serotonin Hyperreactivity and Metabolic Reprogramming in Coronary Arteries via NOX1/4-TRPM2 Signaling Pathway.
    Hypertension. 2024 Jan 4. doi: 10.1161/HYPERTENSIONAHA.123.21345.
    >> Share

  13. LI W, Wang Z, Jiang C, Hua C, et al
    Effect of Intensive Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors.
    Hypertension. 2024 Jan 2. doi: 10.1161/HYPERTENSIONAHA.123.22194.
    >> Share

  14. MITCHELL GF, Rong J, Larson MG, Korzinski TJ, et al
    Vascular Age Assessed From an Uncalibrated, Noninvasive Pressure Waveform by Using a Deep Learning Approach: The AI-VascularAge Model.
    Hypertension. 2024;81:193-201.
    >> Share

    December 2023
  15. PETRAK O, Kratka Z, Holaj R, Zitek M, et al
    Cardiovascular Complications in Pheochromocytoma and Paraganglioma: Does Phenotype Matter?
    Hypertension. 2023 Dec 28. doi: 10.1161/HYPERTENSIONAHA.123.21902.
    >> Share

  16. CHATURVEDI A, Zhu A, Vaishnavi Gadela N, Prabhakaran D, et al
    Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases.
    Hypertension. 2023 Dec 28. doi: 10.1161/HYPERTENSIONAHA.123.21354.
    >> Share

  17. CHO SMJ, Lee H, Koyama S, Zou RS, et al
    Cumulative Diastolic Blood Pressure Burden in Normal Systolic Blood Pressure and Cardiovascular Disease.
    Hypertension. 2023 Dec 12. doi: 10.1161/HYPERTENSIONAHA.123.22160.
    >> Share

  18. KARIO K, Okawara Y, Kanegae H, Hoshide S, et al
    Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended.
    Hypertension. 2023 Dec 11. doi: 10.1161/HYPERTENSIONAHA.123.22122.
    >> Share

  19. YANG R, Huang R, Zhang L, Li D, et al
    Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering: Results From the STEP Randomized Trial.
    Hypertension. 2023;80:2572-2580.
    >> Share

    September 2023
  20. CHUNG J, Robinson C, Sheffield L, Paramanathan P, et al
    Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Hypertension. 2023 Sep 22. doi: 10.1161/HYPERTENSIONAHA.123.20967.
    >> Share

  21. PAJEWSKI NM, Donohue MC, Raman R, Espeland MA, et al
    Ascertainment and Statistical Issues for Randomized Trials of Cardiovascular Interventions for Cognitive Impairment and Dementia: Dementia Series.
    Hypertension. 2023 Sep 21. doi: 10.1161/HYPERTENSIONAHA.123.19941.
    >> Share

  22. NARITA K, Hoshide S, Kario K
    Comparison of Ambulatory and Home Blood Pressure Variability for Cardiovascular Prognosis and Biomarkers.
    Hypertension. 2023 Sep 6. doi: 10.1161/HYPERTENSIONAHA.123.20897.
    >> Share

  23. XIANG B, Zhou Y, Wu X, Zhou X, et al
    Association of Device-Measured Physical Activity With Cardiovascular Outcomes in Individuals With Hypertension.
    Hypertension. 2023 Sep 5. doi: 10.1161/HYPERTENSIONAHA.123.21663.
    >> Share

  24. SOLIMAN EZ, Mills KT
    Exploring the Relationship Between Intensive Blood Pressure Lowering, Left Ventricular Hypertrophy, and Cardiovascular Outcomes.
    Hypertension. 2023;80:1843-1844.
    >> Share

  25. WARREN J, Dinh D, Brennan A, Tan C, et al
    Impact of Preprocedural Diastolic Blood Pressure on Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Hypertension. 2023 Sep 1. doi: 10.1161/HYPERTENSIONAHA.123.20963.
    >> Share

    August 2023
  26. DESBIENS LC, Nadeau-Fredette AC, Madore F, Agharazii M, et al
    Impact of Successive Office Blood Pressure Measurements During a Single Visit on Cardiovascular Risk Prediction: Analysis of CARTaGENE.
    Hypertension. 2023 Aug 24. doi: 10.1161/HYPERTENSIONAHA.123.21510.
    >> Share

  27. SUN X, Feng Y, Gong C, Bao X, et al
    Hypertension-Driven Regulatory T-Cell Perturbations Accelerate Myocardial Ischemia-Reperfusion Injury.
    Hypertension. 2023 Aug 24. doi: 10.1161/HYPERTENSIONAHA.123.20481.
    >> Share

  28. COHEN DL, Wachtel H, Vaidya A, Hundemer GL, et al
    Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management.
    Hypertension. 2023 Aug 18. doi: 10.1161/HYPERTENSIONAHA.123.21474.
    >> Share

  29. TOMIYAMA H, Imai T, Shiina K, Higashi Y, et al
    Lifelong Heterogeneous Contribution of Cardiovascular Risk Factors to Slow and Fast Progression of Arterial Stiffness.
    Hypertension. 2023 Aug 8. doi: 10.1161/HYPERTENSIONAHA.123.21481.
    >> Share

  30. HWANG IC, Kim CH, Kim JY, Choi HM, et al
    Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention.
    Hypertension. 2023;80:1697-1706.
    >> Share

    July 2023
  31. JACKSON EK, Tofovic SP, Chen Y, Birder LA, et al
    8-Aminopurines in the Cardiovascular and Renal Systems and Beyond.
    Hypertension. 2023 Jul 28. doi: 10.1161/HYPERTENSIONAHA.123.20582.
    >> Share

  32. BIDEL Z, Nazarzadeh M, Canoy D, Copland E, et al
    Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis.
    Hypertension. 2023 Jul 24. doi: 10.1161/HYPERTENSIONAHA.123.21496.
    >> Share

  33. STONE K, Veerasingam D, Meyer ML, Heffernan KS, et al
    Reimagining the Value of Brachial-Ankle Pulse Wave Velocity as a Biomarker of Cardiovascular Disease Risk-A Call to Action on Behalf of VascAgeNet.
    Hypertension. 2023 Jul 20. doi: 10.1161/HYPERTENSIONAHA.123.21314.
    >> Share

  34. MATHIEU NM, Nakagawa P, Grobe JL, Sigmund CD, et al
    Insights Into the Role of Angiotensin-II AT(1) Receptor-Dependent beta-Arrestin Signaling in Cardiovascular Disease.
    Hypertension. 2023 Jul 14. doi: 10.1161/HYPERTENSIONAHA.123.19419.
    >> Share

    June 2023
  35. YANG C, Baker PN, Granger JP, Davidge ST, et al
    Long-Term Impacts of Preeclampsia on the Cardiovascular System of Mother and Offspring.
    Hypertension. 2023 Jun 28. doi: 10.1161/HYPERTENSIONAHA.123.21061.
    >> Share

    May 2023
  36. ELFASSY T, German C, Muntner P, Choi E, et al
    Blood Pressure and Cardiovascular Disease Mortality Among US Adults: A Sex-Stratified Analysis, 1999-2019.
    Hypertension. 2023 May 31. doi: 10.1161/HYPERTENSIONAHA.123.21228.
    >> Share

  37. YANG Q, Zheng R, Wang S, Zhu J, et al
    Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Mortality in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Hypertension. 2023 May 31. doi: 10.1161/HYPERTENSIONAHA.123.20954.
    >> Share

  38. XIA X, Qiu C, Rizzuto D, Fratiglioni L, et al
    Role of Orthostatic Hypotension in the Development of Dementia in People With and Without Cardiovascular Disease.
    Hypertension. 2023 May 19. doi: 10.1161/HYPERTENSIONAHA.123.21210.
    >> Share

  39. AL KHALAF S, Chappell LC, Khashan AS, McCarthy FP, et al
    Association Between Chronic Hypertension and the Risk of 12 Cardiovascular Diseases Among Parous Women: The Role of Adverse Pregnancy Outcomes.
    Hypertension. 2023 May 12. doi: 10.1161/HYPERTENSIONAHA.122.20628.
    >> Share

  40. YU J, Song Q, Bai J, Wu S, et al
    Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP Trial.
    Hypertension. 2023 May 12. doi: 10.1161/HYPERTENSIONAHA.122.20376.
    >> Share

  41. LEMBO M, Acampa W, Elena Rao MA, Manzi MV, et al
    Left Ventricular Mechano-Energetic Efficiency Identifies an Early Impairment of Myocardial Blood Flow in Arterial Hypertension.
    Hypertension. 2023 May 12. doi: 10.1161/HYPERTENSIONAHA.123.21071.
    >> Share

    April 2023
  42. BOMBELLI M, Vanoli J, Facchetti R, Maloberti A, et al
    Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: a Prospective Cohort Study.
    Hypertension. 2023 Apr 19. doi: 10.1161/HYPERTENSIONAHA.122.19988.
    >> Share

  43. AHMED N, Kassis A, Malone J, Yang J, et al
    Prenatal Morphine Exposure Increases Cardiovascular Disease Risk and Programs Neurogenic Hypertension in the Adult Offspring.
    Hypertension. 2023 Apr 12. doi: 10.1161/HYPERTENSIONAHA.122.20262.
    >> Share


  44. Correction to: Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy.
    Hypertension. 2023;80:e74.
    >> Share

  45. LIU L, Jouve C, Henry J, Berrandou TE, et al
    Genomic, Transcriptomic, and Proteomic Depiction of Induced Pluripotent Stem Cells-Derived Smooth Muscle Cells As Emerging Cellular Models for Arterial Diseases.
    Hypertension. 2023;80:740-753.
    >> Share

    March 2023
  46. SCHMIEDER RE, Wassmann S, Predel HG, Weisser B, et al
    Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
    Hypertension. 2023 Mar 29. doi: 10.1161/HYPERTENSIONAHA.122.20810.
    >> Share

  47. CAMERON NA, Everitt IK, Lee KA, Yee LM, et al
    Chronic Hypertension in Pregnancy: A Lens Into Cardiovascular Disease Risk and Prevention.
    Hypertension. 2023 Mar 24. doi: 10.1161/HYPERTENSIONAHA.122.19317.
    >> Share

  48. ALEXANDER BT, South AM, August P, Bertagnolli M, et al
    Appraising the Preclinical Evidence of the Role of the Renin-Angiotensin-Aldosterone System in Antenatal Programming of Maternal and Offspring Cardiovascular Health Across the Life Course: Moving the Field Forward: A Scientific Statement From the Amer
    Hypertension. 2023 Mar 23. doi: 10.1161/HYP.0000000000000227.
    >> Share

  49. WANG Y, Wang J, Zheng XW, Du MF, et al
    Early-Life Cardiovascular Risk Factor Trajectories and Vascular Aging in Midlife: A 30-Year Prospective Cohort Study.
    Hypertension. 2023 Mar 7. doi: 10.1161/HYPERTENSIONAHA.122.20518.
    >> Share

  50. MCCARTHY CP, Natarajan P
    Systolic Blood Pressure and Cardiovascular Risk: Straightening the Evidence.
    Hypertension. 2023;80:577-579.
    >> Share

    February 2023
  51. BUTEL-SIMOES LE, Haw TJ, Williams T, Sritharan S, et al
    Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation.
    Hypertension. 2023 Feb 9. doi: 10.1161/HYPERTENSIONAHA.122.17947.
    >> Share

  52. GROBMAN B, Turkson-Ocran RA, Staessen JA, Yu YL, et al
    Body Position and Cardiovascular Events in Hypertensive Adults: An Observational Analysis of the Syst-Eur Trial.
    Hypertension. 2023 Feb 6. doi: 10.1161/HYPERTENSIONAHA.122.20602.
    >> Share

    January 2023
  53. SIDDIQUI M, Hannon L, Wang Z, Blair J, et al
    Hypertension and Cardiovascular Disease Risk Among Individuals With Versus Without HIV.
    Hypertension. 2023 Jan 25. doi: 10.1161/HYPERTENSIONAHA.122.19889.
    >> Share

  54. CLARKE R, Wright N, Walters R, Gan W, et al
    Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults.
    Hypertension. 2023 Jan 5. doi: 10.1161/HYPERTENSIONAHA.122.20120.
    >> Share

  55. WU S, Li M, Lu J, Tang X, et al
    Blood Pressure Levels, Cardiovascular Events, and Renal Outcomes in Chronic Kidney Disease Without Antihypertensive Therapy: A Nationwide Population-Based Cohort Study.
    Hypertension. 2023 Jan 5. doi: 10.1161/HYPERTENSIONAHA.122.19902.
    >> Share

    December 2022
  56. RAO S, Li Y, Nazarzadeh M, Canoy D, et al
    Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.
    Hypertension. 2022 Dec 30. doi: 10.1161/HYPERTENSIONAHA.122.20489.
    >> Share

  57. RIKHI R, Bhatia HS, Schaich CL, Ashburn N, et al
    Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA.
    Hypertension. 2022 Dec 13. doi: 10.1161/HYPERTENSIONAHA.122.20189.
    >> Share


  58. Correction to: Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease.
    Hypertension. 2022;79:e147.
    >> Share

    November 2022
  59. FARIA D, Moll-Bernardes R, Testa L, Moniz CMV, et al
    Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae.
    Hypertension. 2022 Nov 23. doi: 10.1161/HYPERTENSIONAHA.122.19958.
    >> Share

  60. NARITA K, Hoshide S, Kario K
    Association of Home and Ambulatory Blood Pressure With Cardiovascular Prognosis in Practice Hypertensive Outpatients.
    Hypertension. 2022 Nov 17. doi: 10.1161/HYPERTENSIONAHA.122.20178.
    >> Share

  61. DIAZ DEL CAMPO LS, Garcia-Redondo AB, Rodriguez C, Zaragoza C, et al
    Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin Ii-Induced Hypertension.
    Hypertension. 2022 Nov 7. doi: 10.1161/HYPERTENSIONAHA.122.19448.
    >> Share

    October 2022
  62. BUCKLEY LF, Baker WL, Van Tassell BW, Cohen JB, et al
    Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events.
    Hypertension. 2022 Oct 18. doi: 10.1161/HYPERTENSIONAHA.122.20141.
    >> Share

  63. JONES DW, Clark D 3rd, Morgan TO, He FJ, et al
    Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease.
    Hypertension. 2022;79:2199-2201.
    >> Share

  64. KATUNARIC B, SenthilKumar G, Schulz ME, De Oliveira N, et al
    S1P (Sphingosine-1-Phosphate)-Induced Vasodilation in Human Resistance Arterioles During Health and Disease.
    Hypertension. 2022;79:2250-2261.
    >> Share

    September 2022
  65. BIGALKE JA, Shan Z, Carter JR
    Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function.
    Hypertension. 2022 Sep 23:101161HYPERTENSIONAHA12219796.
    >> Share

  66. GYSELAERS W, Dreesen P, Staelens AS, Tomsin K, et al
    First-Trimester Normotension Is a Weak Indicator of Normal Maternal Cardiovascular Function.
    Hypertension. 2022 Sep 23:HYPERTENSIONAHA12219346.
    >> Share

  67. HAMZAOUI M, Groussard D, Nezam D, Djerada Z, et al
    Endothelium-Specific Deficiency of Polycystin-1 Promotes Hypertension and Cardiovascular Disorders.
    Hypertension. 2022 Sep 12:101161HYPERTENSIONAHA12219057.
    >> Share

  68. HUANG Z, Chen Z, Wang X, Ding X, et al
    Association of Cardiovascular Health Score Trajectory With Incident Myocardial Infarction in Hypertensive Patients.
    Hypertension. 2022 Sep 9:101161HYPERTENSIONAHA12219633.
    >> Share

  69. ROSSI GP, Rossitto G
    Aldosterone and Cardiovascular Damage: a New Lesson From an Old Study.
    Hypertension. 2022;79:1994-1996.
    >> Share

    August 2022
  70. JIAN Z, Yuan C, Ma Y
    Blood Pressure Mediated the Effects of Urinary Uromodulin Levels on Myocardial Infarction: a Mendelian Randomization Study.
    Hypertension. 2022 Aug 25:101161HYPERTENSIONAHA12219670.
    >> Share

  71. TRIMARCO V, Izzo R, Morisco C, Mone P, et al
    High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients.
    Hypertension. 2022 Aug 15:101161HYPERTENSIONAHA12219912.
    >> Share

  72. CLARK CE, Warren FC, Boddy K, McDonagh STJ, et al
    Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration.
    Hypertension. 2022 Aug 2:HYPERTENSIONAHA12118921.
    >> Share

  73. YANO Y, Kim HC, Lee H, Azahar N, et al
    Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension - Pro Side of the Argument.
    Hypertension. 2022;79:1563-1570.
    >> Share

  74. JACOBSEN AP, McKittrick M, Daya N, Al Rifai M, et al
    Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension-Con Side of the Argument.
    Hypertension. 2022;79:1571-1578.
    >> Share

  75. YANO Y, Chang Kim H, Lee H, Azahar N, et al
    Response to Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension - Con Side of the Argument.
    Hypertension. 2022;79:1579.
    >> Share

  76. JACOBSEN AP, McKittrick M, Daya N, Al Rifai M, et al
    Response to Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension - Con Side of the Argument.
    Hypertension. 2022;79:1570.
    >> Share

  77. PICONE DS, Stoneman E, Cremer A, Schultz MG, et al
    Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management.
    Hypertension. 2022 Aug 1:HYPERTENSIONAHA12219693.
    >> Share

    July 2022
  78. CRUZ-LOPEZ EO, Ye D, Wu C, Lu HS, et al
    Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease.
    Hypertension. 2022 Jul 29:101161HYPERTENSIONAHA12218731.
    >> Share

  79. GIORGIONE V, Jansen G, Kitt J, Ghossein-Doha C, et al
    Peripartum and Long-Term Maternal Cardiovascular Health After Preeclampsia.
    Hypertension. 2022 Jul 29:101161HYPERTENSIONAHA12218730.
    >> Share

  80. JAE SY, Lee KH, Kim HJ, Kunutsor SK, et al
    Separate and Joint Associations of Cardiorespiratory Fitness and Healthy Vascular Aging With Subclinical Atherosclerosis in Men.
    Hypertension. 2022;79:1445-1454.
    >> Share

    June 2022
  81. NARITA K, Hoshide S, Kario K
    Seasonal Variation in Day-by-Day Home Blood Pressure Variability and Effect on Cardiovascular Disease Incidence.
    Hypertension. 2022 Jun 30:101161HYPERTENSIONAHA12219494.
    >> Share

  82. BUFFOLO F, Tetti M, Mulatero P, Monticone S, et al
    Aldosterone as a Mediator of Cardiovascular Damage.
    Hypertension. 2022 Jun 29:101161HYPERTENSIONAHA12217964.
    >> Share

  83. WANG A, Tian X, Zuo Y, Chen S, et al
    Control of Blood Pressure and Risk of Cardiovascular Disease and Mortality in Elderly Chinese: A Real-World Prospective Cohort Study.
    Hypertension. 2022 Jun 15:101161HYPERTENSIONAHA12219587.
    >> Share

  84. BORGHI C, Agnoletti D, Cicero AFG, Lurbe E, et al
    Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk.
    Hypertension. 2022 Jun 6:101161HYPERTENSIONAHA12217956.
    >> Share

    April 2022
  85. YUN H, Sun L, Wu Q, Luo Y, et al
    Lipidomic Signatures of Dairy Consumption and Associated Changes in Blood Pressure and Other Cardiovascular Risk Factors Among Chinese Adults.
    Hypertension. 2022 Apr 26:101161HYPERTENSIONAHA12218981.
    >> Share

  86. MUZUROVIC E, Peng CC, Belanger MJ, Sanoudou D, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors.
    Hypertension. 2022 Apr 25:101161HYPERTENSIONAHA12217982.
    >> Share

  87. PARCHA V, Pampana A, Bress AP, Irvin MR, et al
    Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial.
    Hypertension. 2022 Apr 4:HYPERTENSIONAHA12218976.
    >> Share

    March 2022
  88. YAN LD, Matuja SS, Pain KJ, McNairy ML, et al
    Emerging Viral Infections, Hypertension, and Cardiovascular Disease in Sub-Saharan Africa: A Narrative Review.
    Hypertension. 2022 Mar 11:HYPERTENSIONAHA12117949.
    >> Share


  89. Correction to: Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independently of Nitric Oxide In Vivo.
    Hypertension. 2022;79:e71.
    >> Share

  90. SUVILA K, Niiranen TJ
    Interrelations Between High Blood Pressure, Organ Damage, and Cardiovascular Disease: No More Room for Doubt.
    Hypertension. 2022;79:516-517.
    >> Share

    February 2022
  91. VALENCIA-HERNANDEZ CA, Lindbohm JV, Shipley MJ, Wilkinson IB, et al
    Aortic Pulse Wave Velocity as Adjunct Risk Marker for Assessing Cardiovascular Disease Risk: Prospective Study.
    Hypertension. 2022 Feb 10:HYPERTENSIONAHA12117589.
    >> Share

  92. CARDOSO CRL, Salles GF
    Prognostic Value of Changes in Aortic Stiffness for Cardiovascular Outcomes and Mortality in Resistant Hypertension: a Cohort Study.
    Hypertension. 2022;79:447-456.
    >> Share

  93. MTHEMBU N, Norton GR, Peterson VR, Naran R, et al
    Increased Backward Wave Pressures Rather than Flow Explain Age-Dependent Heart Rate Effects on Central, But not Peripheral Arterial Pressure.
    Hypertension. 2022;79:435-446.
    >> Share

    January 2022
  94. PEWOWARUK RJ, Korcarz C, Tedla Y, Burke G, et al
    Carotid Artery Stiffness Mechanisms Associated With Cardiovascular Disease Events and Incident Hypertension: the MESA.
    Hypertension. 2022 Jan 13:HYPERTENSIONAHA12118772.
    >> Share

  95. LATOSINSKA A, Bruno RM, Pappaccogli M, Bacca A, et al
    Increased Collagen Turnover Is a Feature of Fibromuscular Dysplasia and Associated With Hypertrophic Radial Remodeling: A Pilot, Urine Proteomic Study.
    Hypertension. 2022;79:93-103.
    >> Share

    December 2021
  96. NARITA K, Hoshide S, Kario K
    Nighttime Home Blood Pressure Is Associated With the Cardiovascular Disease Events Risk in Treatment-Resistant Hypertension.
    Hypertension. 2021 Dec 10:HYPERTENSIONAHA12118534.
    >> Share

  97. ZHAO Y, Rahmouni K
    BBSome: a New Player in Hypertension and Other Cardiovascular Risks.
    Hypertension. 2021 Dec 6:HYPERTENSIONAHA12117946.
    >> Share

  98. HAHAD O, Daiber A, Munzel T
    Reduced Aircraft Noise Pollution During COVID-19 Lockdown Is Beneficial to Public Cardiovascular Health: a Perspective on the Reduction of Transportation-Associated Pollution.
    Hypertension. 2021 Dec 6:HYPERTENSIONAHA12118607.
    >> Share

  99. LAKSHMAN R, Spiroski AM, McIver LB, Murphy MP, et al
    Noninvasive Biomarkers for Cardiovascular Dysfunction Programmed in Male Offspring of Adverse Pregnancy.
    Hypertension. 2021;78:1818-1828.
    >> Share

    November 2021
  100. CERDEIRA AS, Rana S, Karumanchi SA
    Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease?
    Hypertension. 2021;78:1395-1397.
    >> Share

  101. BORGHI C, Piani F
    Uric Acid and Risk of Cardiovascular Disease: A Question of Start and Finish.
    Hypertension. 2021;78:1219-1221.
    >> Share

  102. SCHUTTE AE, Gnanenthiran SR
    Toward a Better Understanding of Why Cumulative Blood Pressure Is Such a Strong Predictor of Cardiovascular Outcomes.
    Hypertension. 2021;78:1267-1269.
    >> Share

  103. KARIO K, Hoshide S, Narita K, Okawara Y, et al
    Cardiovascular Prognosis in Drug-Resistant Hypertension Stratified by 24-Hour Ambulatory Blood Pressure: The JAMP Study.
    Hypertension. 2021 Nov 1:HYPERTENSIONAHA12118198.
    >> Share

    October 2021
  104. VASAN RS, Song RJ, Xanthakis V, Mitchell GF, et al
    Aortic Root Diameter and Arterial Stiffness: Conjoint Relations to the Incidence of Cardiovascular Disease in the Framingham Heart Study.
    Hypertension. 2021 Oct 4:HYPERTENSIONAHA12117702.
    >> Share

  105. VASAN RS, Pan S, Larson MG, Mitchell GF, et al
    Arteriosclerosis, Atherosclerosis, and Cardiovascular Health: Joint Relations to the Incidence of Cardiovascular Disease.
    Hypertension. 2021 Oct 4:HYPERTENSIONAHA12118075.
    >> Share

    September 2021
  106. CARDOSO CRL, Salles GF
    Prognostic Impact of Home Blood Pressures for Adverse Cardiovascular Outcomes and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study.
    Hypertension. 2021 Sep 27:HYPERTENSIONAHA12118064.
    >> Share

    June 2021
  107. AKWO EA, Robinson-Cohen C, Chung CP, Shah SC, et al
    Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program.
    Hypertension. 2021 Jun 21:HYPERTENSIONAHA12016181.
    >> Share

  108. ZHOU Z, Xing AJ, Zhang JN, Xia WH, et al
    Hypertension, Arterial Stiffness, and Clinical Outcomes: A Cohort Study of Chinese Community-Based Population.
    Hypertension. 2021 Jun 14:HYPERTENSIONAHA12117131.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016